The Immunisation Handbook 2017 (the Handbook) provides clinical guidelines for health professionals on the safest and most effective use of vaccines in their practice. These guidelines are based on the best scientific evidence available at the time of publication, from published and unpublished literature.
Read the handbook
To read the Immunisation Handbook you can:
- download a PDF of the Immunisation Handbook (PDF, 7.4 MB)
- download an ebook version of the Immunisation Handbook (epub, 1.8 MB)
- download individual chapters of the Immunisation Handbook below.
Refer to the Pharmaceutical Schedule (on the Pharmac website) for the number of funded doses, eligibility criteria and any subsequent changes to the funding decisions
Changes to the 2017 edition
All chapters have been updated and revised since the 2014 edition. The following changes have been made.
- There is a new section at the end of each disease chapter called ‘Variations from the vaccine data sheets’.
- The content from chapter 2 ‘Processes for safe immunisation’ has been reformatted into pre-vaccination, vaccine administration and post-vaccination sections.
- The ‘Passive immunisation’ section of chapter 1 has been moved to its own appendix (Appendix 6).
- The ‘Cold chain: vaccine storage, transport and destruction’ appendix has been removed and its content is now included in the Ministry of Health document National Standards for Vaccine Storage and Transportation for Immunisation Providers 2017.
- The ‘Notifiable disease case definitions and laboratory tests’ appendix (Appendix 8) has been removed. Health care providers should use the Ministry of Health’s Communicable Disease Control Manual 2012 for case definition and laboratory test information.
- There is a new appendix, ‘High-incidence TB countries’ (Appendix 8), with a list of countries with tuberculosis (TB) rates of ≥40 per 100,000 population.
- Introduction (PDF, 1.1 MB)
- 1. General immunisation principles (PDF, 857 KB)
- 2. Processes for safe immunisation (PDF, 2.5 MB)
- 3. Vaccination questions and addressing concerns (PDF, 336 KB)
- 4. Immunisation of special groups (PDF, 1.1 MB)
- 5. Diphtheria (PDF, 467 KB)
- 6. Haemophilus inﬂuenzae type b (Hib) disease (PDF, 363 KB)
- 7. Hepatitis A (PDF, 385 KB)
- 8. Hepatitis B (PDF, 590 KB)
- 9. Human papillomavirus (HPV) (PDF, 508 KB)
- 10. Inﬂuenza (PDF, 629 KB)
- 11. Measles (PDF, 410 KB)
- 12. Meningococcal disease (PDF, 499 KB)
- 13. Mumps (PDF, 314 KB)
- 14. Pertussis (whooping cough) (PDF, 560 KB)
- 15. Pneumococcal disease (PDF, 632 KB)
- 16. Poliomyelitis (PDF, 300 KB)
- 17. Rotavirus (PDF, 416 KB)
- 18. Rubella (PDF, 358 KB)
- 19. Tetanus (PDF, 385 KB)
- 20. Tuberculosis (PDF, 401 KB)
- 21. Varicella (chickenpox) (PDF, 489 KB)
- 22. Zoster (herpes zoster/shingles) (PDF, 286 KB)
- Appendix 1: The history of immunisation in New Zealand (PDF, 438 KB)
- Appendix 2: Planning immunisation catch-ups (PDF, 313 KB)
- Appendix 3: Immunisation standards for vaccinators and guidelines for organisations offering immunisation services (PDF, 272 KB)
- Appendix 4: Authorisation of vaccinators and criteria for pharmacist vaccinators (PDF, 350 KB)
- Appendix 5: Immunisation certiﬁcate (PDF, 186 KB)
- Appendix 6: Passive immunisation (PDF, 342 KB)
- Appendix 7: Vaccine presentation, preparation, disposal, and needle-stick recommendations (PDF, 210 KB)
- Appendix 8: High-incidence TB countries (PDF, 275 KB)
- Appendix 9: Websites (PDF, 164 KB)
- Index (PDF, 445 KB)
- Funded vaccines for special groups (PDF, 225 KB)